Showing results (341-350 of 456) with videos related to
Sort By:
Pageof 46
Digestive Diseases and Sciences|August 24, 2018
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 AnalysisSang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.The Lancet. Gastroenterology & Hepatology|June 20, 2024
Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 studyHarry L A Janssen, Young-Suk Lim, Pietro Lampertico, et al.The Journal of Infectious Diseases|April 9, 2019
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated SubstitutionsChung-Feng Huang, Chao-Hung Hung, Pin-Nan Cheng, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 15, 2023
A people-centered decentralized outreach model toward HCV micro-elimination in hyperendemic areas: COMPACT study in SARS Co-V2 pandemicChing-I Huang, Po-Cheng Liang, Yu-Ju Wei, et al.Journal of Gastroenterology and Hepatology|July 28, 2021
Seroreversion of hepatitis B surface antigen among subjects with resolved hepatitis B virus infection: A community-based cohort studyMing-Lun Yeh, Po-Cheng Liang, Ching-I Huang, et al.BMJ Open|March 16, 2021
Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in TaiwanPei-Chien Tsai, Ching-I Huang, Ming-Lun Yeh, et al.The Kaohsiung Journal of Medical Sciences|June 7, 2022
Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetesTyng-Yuan Jang, Yi-Hung Lin, Po-Cheng Liang, et al.The Kaohsiung Journal of Medical Sciences|April 29, 2022
Low disease awareness as a contributing factor to the high prevalence of hepatitis C infection in Tzukuan, a hyperendemic area of southern TaiwanPei-Chien Tsai, Chia-Yen Dai, Ching-I Huang, et al.Alimentary Pharmacology & Therapeutics|March 6, 2020
Modelling NAFLD disease burden in four Asian regions-2019-2030Chris Estes, Henry L Y Chan, Rong N Chien, et al.Gastroenterology|June 9, 2016
Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver CancerMei-Hwei Chang, San-Lin You, Chien-Jen Chen, et al.Pageof 46